| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |